Researchers are exploring ways to improve management of multiple sclerosis in older adults, with some studies focusing on the efficacy and safety of various treatments, including cladribine tablets and B-cell therapy. Certain therapies, such as ocrelizumab, have shown promise in slowing disability progression in patients with primary progressive multiple sclerosis. The field is seeing advancements, with new grants and research initiatives aimed at improving understanding and treatment of the disease.